Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Survivors Of Childhood Central Nervous System Cancer Face Persistent Risks As Adults
Long-term survivors of childhood central nervous system (CNS) malignancies remain at risk for death and are at increasing risk for developing subsequent cancers and chronic medical conditions over time, according to a new study published online June 17 in the JNCI.

Progress Seen In Some African HIV/AIDS Prevention, Treatment Programs, U.N. Special Envoy Says At World Economic Forum On Africa
Several African countries have successfully scaled up their HIV/AIDS prevention and treatment programs, U.N. Special Envoy for HIV and AIDS in Africa Elizabeth Mataka said during a media briefing at the World Economic Forum on Africa being held in Cape Town, South Africa, the ZANIS/Lusaka Times reports. Zambia and Botswana were among some of the countries that have made significant progress in southern Africa, according to Mataka.
News of the day
ASGS Issues Position Statement Supporting TIF Natural Orifice Surgery For GERD
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), announced that the American Society of General Surgeons (ASGS) has published a position statement endorsing its Transoral Incisionless Fundoplication (TIF) procedure for the treatment of GERD. ASGS is the preeminent society of general surgeons with membership exceeding 2,000.
Oncology

Health Canada Approves Innovotech Application For AgressTM Field Testing

The Pest Management Regulatory Agency of Health Canada has granted Innovotech (TSV VENTURE:IOT) a Research Authorization for large-scale field trials for the 2009 season to test its novel seed treatment, AgressTM. This Research Authorization provides growers with an opportunity to assess the real-world ability of AgressTM to fight bacterial disease and its ease of use. In conjunction with cooperating growers, dry beans treated with AgressTM have been planted on farms in Alberta. "These large-scale field trials give us an opportunity to test AgressTM on a commercial scale that would be used by a grower," says Damian Sowa, Product Manager, Innovotech. "We will also use the trials to validate our small plot results that showed AgressTM to be a superior and long sought replacement for Streptomycin in bacterial infestations of beans." Research is currently underway to expand the applications of AgressTM to include the major crops in North America and additional disease classes. Innovotech Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009